Pattern of recurrence and survival in TNBC-a retrospective study done in a rural based medical college and hospital of West Bengal India

Pattern of recurrence and survival in TNBC-a retrospective study done in a rural based medical college and hospital of West Bengal India

Introduction: Triple-Negative Breast Cancer (TNBC) constitutes patients with estrogen and progesterone hormone receptors negativity, Her 2-neu negativity and variable expressions of Ki67 (proliferative marker), EGFR and CK 5/6 cytokeratins. Standard treatment protocols have failed to improve the ove...

Full description

Bibliographic Details
Main Authors:	Acharya, S. (Author), Basu, A. (Author), Bhattacharyya, P. (Author), Choudhury, K.B (Author), Dasgupta, P. (Author), Mandal, S.K (Author)
Format:	Article
Language:	English
Published:	Radiance Research Academy 2021
Subjects:	HER2 mutation Rural population Triple Negative Breast Cancer
Online Access:	View Fulltext in Publisher

Similar Items

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
by: Tejaswini P. Reddy, et al.
Published: (2020-05-01)

A Comparison of Clinical Features, Pathology and Outcomes in Various Subtypes of Breast Cancer in Indian Women
by: Anupama Mane, et al.
Published: (2015-09-01)

Current approaches in treatment of triple-negative breast cancer
by: Hanan Ahmed Wahba, et al.
Published: (2015-06-01)

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening
by: Jangsoon Lee, et al.
Published: (2021-06-01)

Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape
by: Garbar C, et al.
Published: (2018-05-01)

The Landscape of Targeted Therapies in TNBC
by: Elena Vagia, et al.
Published: (2020-04-01)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
by: Hoon Sik Choi, et al.
Published: (2021-08-01)

Genetic Counseling in the Follow-up of Breast Cancer patients; Conversion of a Luminal Tumor to TNBC
by: Hamid Ahmadi, et al.
Published: (2020-02-01)

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
by: Shavira Narrandes, et al.
Published: (2018-01-01)

Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status
by: Man Yee Keung, et al.
Published: (2020-03-01)

1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel
by: Karan Modi, et al.
Published: (2020-08-01)

Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
by: Mlole AT, et al.
Published: (2020-11-01)

TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
by: Desh Deepak Singh, et al.
Published: (2021-07-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
by: Gabriela Morales-Guadarrama, et al.
Published: (2021-07-01)

Epidemiological and pathological characteristics of postsurgical cases of invasive breast cancer among ethnicities of Iran in 2018: A single center cross-sectional study
by: Sayad Soheila, et al.
Published: (2020-01-01)

Clinical characteristics of triple negative breast cancer in Egyptian women: a hospital-based experience
by: Nivine Gado, et al.
Published: (2016-06-01)

Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery
by: Zachary Quinn, et al.
Published: (2021-03-01)

Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells
by: Andrew Sulaiman, et al.
Published: (2020-08-01)

Investigation of TNBC in vitro Antiproliferative Effects of Versatile Pirrolo[1,2-a]quinoxaline Compounds
by: Mariarita Perri, et al.
Published: (2019-03-01)

Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
by: Reyhaneh Farghadani, et al.
Published: (2021-07-01)

Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
by: M. Ángeles López-García, et al.
Published: (2020-06-01)

Atypical glandular cells: Help or hindrance
by: Sanjeev Narang, et al.
Published: (2018-04-01)

Immunohistoochemical evaluation of GATA-3, pAKT and Ki-67 in triple negative breast carcinoma
by: Gopi Aryal, et al.
Published: (2017-09-01)

Age-related Variation in Expression of Breast Cancer Tumour Markers in Iranian Patients
by: Fatemeh Homaei Shandiz, et al.
Published: (2021-04-01)

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide
by: Adam C. Mirando, et al.
Published: (2020-01-01)

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer
by: Alberto Montero, et al.
Published: (2012-12-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Leila Rahmani, et al.
Published: (2012-03-01)

Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: A Comparative Study
by: Tahere Zarouk Ahimahalle, et al.
Published: (2012-01-01)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
by: Daniele La Forgia, et al.
Published: (2020-09-01)

Triple Negative Breast Cancer-An Overview and Review of Literature
by: Amit Gupta
Published: (2013-02-01)

Precision medicine in breast cancer: reality or utopia?
by: Ali Bettaieb, et al.
Published: (2017-06-01)

Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival
by: Abdulla Al-Rashdan, et al.
Published: (2021-10-01)

Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach
by: Guangyuan Yu, et al.
Published: (2020-09-01)

Globally ncRNAs Expression Profiling of TNBC and Screening of Functional lncRNA
by: Aman Chandra Kaushik, et al.
Published: (2021-01-01)

Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
by: Amal Qattan, et al.
Published: (2021-04-01)

Long-term survival and stage I breast cancer subtypes
by: Skye Hung-Chun Cheng, et al.
Published: (2016-03-01)

Two activating mutations of MPL in triple‐negative myeloproliferative neoplasms
by: Juan Xie, et al.
Published: (2019-09-01)

Immune characterization of breast cancer metastases: prognostic implications
by: Maria Vittoria Dieci, et al.
Published: (2018-06-01)

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
by: Ines Stevic, et al.
Published: (2018-10-01)